Research Group @ Chair of Experimental Bioinformatics @ TUM
Our group aims to elucidate the molecular mechanisms behind phenotypes in general and human diseases, in particular. To that end, we develop integrative bioinformatics methods leveraging network analysis, machine learning techniques, and statistical approaches. We apply own and existing approaches in close collaboration with biologists and physicians to derive insights from multi-omics data.
We develop tools that leverage information from molecular interaction networks in understanding molecular profiling data. De novo network enrichment tools extract subnetworks that mechanistically explain a phenotype of interest, e.g. a disease.
The EU H2020 project FeatureCloud aims at developing methods for privacy-preserving, federated machine learning.
The EU H2020 project REPO-TRIAL aims at developing an in silico approach to optimise the efficacy and precision of drug repurposing trials. To this end we integrate heterogeneous data into a comprehensive interactome of disease-drug-gene interactions (a new diseasome) and develop graph-based machine learning approaches to investigate this highly complex data.